{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:53:20Z","timestamp":1793937200015,"version":"4.8.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"8106","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,3,19]]},"DOI":"10.1038\/s41586-025-10052-8","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:03:24Z","timestamp":1769616204000},"page":"808-818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["GlycoRNA complexed with heparan sulfate regulates VEGF-A signalling"],"prefix":"10.1038","volume":"651","author":[{"given":"Peiyuan","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9934-4297","authenticated-orcid":false,"given":"Sina","family":"Kheiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0760-4232","authenticated-orcid":false,"given":"Jessica","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Kageler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0014-2565","authenticated-orcid":false,"given":"Jonathan","family":"Perr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1709-4635","authenticated-orcid":false,"given":"Jennifer","family":"Porat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotta G.","family":"Lebedenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao M. L.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2913-0012","authenticated-orcid":false,"given":"Eliza","family":"Yankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep K.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petar","family":"Hristov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4865-7648","authenticated-orcid":false,"given":"Konstantinos","family":"Tzelepis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8355-4065","authenticated-orcid":false,"given":"Timothy","family":"Hla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3006-2742","authenticated-orcid":false,"given":"Eliezer","family":"Calo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-1834","authenticated-orcid":false,"given":"Jeffrey D.","family":"Esko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5013-0442","authenticated-orcid":false,"given":"Ryan A.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"10052_CR1","doi-asserted-by":"publisher","first-page":"a004952","DOI":"10.1101\/cshperspect.a004952","volume":"3","author":"S Sarrazin","year":"2011","unstructured":"Sarrazin, S., Lamanna, W. C. & Esko, J. D. Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 3, a004952 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10052_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cellsig.2018.11.022","volume":"54","author":"M Xie","year":"2019","unstructured":"Xie, M. & Li, J.-P. Heparan sulfate proteoglycan \u2014 a common receptor for diverse cytokines. Cell Signal. 54, 115\u2013121 (2019).","journal-title":"Cell Signal."},{"key":"10052_CR3","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte, R. S., Chen, D. S. & Ferrara, N. VEGF in signaling and disease: beyond discovery and development. Cell 176, 1248\u20131264 (2019).","journal-title":"Cell"},{"key":"10052_CR4","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1074\/jbc.M510760200","volume":"281","author":"CJ Robinson","year":"2006","unstructured":"Robinson, C. J., Mulloy, B., Gallagher, J. T. & Stringer, S. E. VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J. Biol. Chem. 281, 1731\u20131740 (2006).","journal-title":"J. Biol. Chem."},{"key":"10052_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1074\/jbc.M110.177006","volume":"286","author":"D Xu","year":"2011","unstructured":"Xu, D., Fuster, M. M., Lawrence, R. & Esko, J. D. Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. J. Biol. Chem. 286, 737\u2013745 (2011).","journal-title":"J. Biol. Chem."},{"key":"10052_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09605-z","volume":"10","author":"F Corti","year":"2019","unstructured":"Corti, F. et al. N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA165-dependent neovascularization. Nat. Commun. 10, 1562 (2019).","journal-title":"Nat. Commun."},{"key":"10052_CR7","doi-asserted-by":"publisher","first-page":"36132","DOI":"10.1074\/jbc.M112.384875","volume":"287","author":"C Ferreras","year":"2012","unstructured":"Ferreras, C. et al. Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor. J. Biol. Chem. 287, 36132\u201336146 (2012).","journal-title":"J. Biol. Chem."},{"key":"10052_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.devcel.2006.03.009","volume":"10","author":"L Jakobsson","year":"2006","unstructured":"Jakobsson, L. et al. Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev. Cell 10, 625\u201334 (2006).","journal-title":"Dev. Cell"},{"key":"10052_CR9","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1016\/j.cell.2021.04.023","volume":"184","author":"RA Flynn","year":"2021","unstructured":"Flynn, R. A. et al. Small RNAs are modified with N-glycans and displayed on the surface of living cells. Cell 184, 3109\u20133124.e22 (2021).","journal-title":"Cell"},{"key":"10052_CR10","doi-asserted-by":"publisher","unstructured":"Xie, Y. et al. The modified RNA base acp3U is an attachment site for N-glycans in glycoRNA. Cell https:\/\/doi.org\/10.1016\/j.cell.2024.07.044 (2024).","DOI":"10.1016\/j.cell.2024.07.044"},{"key":"10052_CR11","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.cell.2025.01.040","volume":"188","author":"J Perr","year":"2025","unstructured":"Perr, J. et al. RNA-binding proteins and glycoRNAs form domains on the cell surface for cell-penetrating peptide entry. Cell 188, 1878\u20131895.e25 (2025).","journal-title":"Cell"},{"key":"10052_CR12","doi-asserted-by":"publisher","unstructured":"George, B. et al. Targeting cell surface NPM1 as a therapeutic strategy against acute myeloid leukemia. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-025-02648-2 (2025).","DOI":"10.1038\/s41587-025-02648-2"},{"key":"10052_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","volume":"6","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct. Target. Ther. 6, 153 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"10052_CR14","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.copbio.2013.04.011","volume":"24","author":"KC Clause","year":"2013","unstructured":"Clause, K. C. & Barker, T. H. Extracellular matrix signaling in morphogenesis and repair. Curr. Opin. Biotechnol. 24, 830\u2013833 (2013).","journal-title":"Curr. Opin. Biotechnol."},{"key":"10052_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bbrc.2008.07.121","volume":"375","author":"R Roskoski","year":"2008","unstructured":"Roskoski, R. VEGF receptor protein-tyrosine kinases: structure and regulation. Biochem. Biophys. Res. Commun. 375, 287\u2013291 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10052_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","volume":"83","author":"D Xu","year":"2014","unstructured":"Xu, D. & Esko, J. D. Demystifying heparan sulfate-protein interactions. Annu. Rev. Biochem. 83, 129\u2013157 (2014).","journal-title":"Annu. Rev. Biochem."},{"key":"10052_CR17","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1182\/blood.V82.11.3253.3253","volume":"82","author":"RM Nelson","year":"1993","unstructured":"Nelson, R. M. et al. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood 82, 3253\u20133258 (1993).","journal-title":"Blood"},{"key":"10052_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","volume":"183","author":"TM Clausen","year":"2020","unstructured":"Clausen, T. M. et al. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell 183, 1043\u20131057.e15 (2020).","journal-title":"Cell"},{"key":"10052_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02145-6","volume":"21","author":"N Huang","year":"2020","unstructured":"Huang, N. et al. Natural display of nuclear-encoded RNA on the cell surface and its impact on cell interaction. Genome Biol. 21, 225 (2020).","journal-title":"Genome Biol."},{"key":"10052_CR20","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.1073\/pnas.71.12.4960","volume":"71","author":"M Rieber","year":"1974","unstructured":"Rieber, M. & Bacalao, J. An \u201cexternal\u201d RNA removable from mammalian cells by mild proteolysis. Proc. Natl Acad. Sci. USA 71, 4960\u20134964 (1974).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10052_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0014-5793(72)80210-2","volume":"22","author":"R Juliano","year":"1972","unstructured":"Juliano, R., Ciszkowski, J., Waite, D. & Mayhew, E. RNA associated with plasma membranes of ehrlich ascites carcinoma cells. FEBS Lett. 22, 27\u201330 (1972).","journal-title":"FEBS Lett."},{"key":"10052_CR22","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41586-025-09310-6","volume":"645","author":"VR Graziano","year":"2025","unstructured":"Graziano, V. R. et al. RNA N-glycosylation enables immune evasion and homeostatic efferocytosis. Nature 645, 784\u2013792 (2025).","journal-title":"Nature"},{"key":"10052_CR23","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cell.2023.12.033","volume":"187","author":"N Zhang","year":"2024","unstructured":"Zhang, N. et al. Cell surface RNAs control neutrophil recruitment. Cell 187, 846\u2013860.e17 (2024).","journal-title":"Cell"},{"key":"10052_CR24","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/s43018-023-00656-2","volume":"4","author":"K Knorr","year":"2023","unstructured":"Knorr, K. et al. Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia. Nat. Cancer 4, 1675\u20131692 (2023).","journal-title":"Nat. Cancer"},{"key":"10052_CR25","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1182\/blood-2006-08-040691","volume":"110","author":"S Fischer","year":"2007","unstructured":"Fischer, S. et al. Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor. Blood 110, 2457\u20132465 (2007).","journal-title":"Blood"},{"key":"10052_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301763","volume":"10","author":"W-P Qin","year":"2023","unstructured":"Qin, W.-P. et al. Effect of extracellular ribonucleic acids on neurovascularization in osteoarthritis. Adv. Sci. 10, e2301763 (2023).","journal-title":"Adv. Sci."},{"key":"10052_CR27","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1096\/fj.08-121608","volume":"23","author":"S Fischer","year":"2009","unstructured":"Fischer, S. et al. Signaling mechanism of extracellular RNA in endothelial cells. FASEB J. 23, 2100\u20132109 (2009).","journal-title":"FASEB J."},{"key":"10052_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/abbs\/gmv131","volume":"48","author":"J Sheng","year":"2016","unstructured":"Sheng, J. & Xu, Z. Three decades of research on angiogenin: a review and perspective. Acta Biochim. Biophys. Sin. 48, 399\u2013410 (2016).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10052_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37140-2","volume":"9","author":"R Ferguson","year":"2019","unstructured":"Ferguson, R., Holloway, D. E., Chandrasekhar, A., Acharya, K. R. & Subramanian, V. The catalytic activity and secretion of zebrafish RNases are essential for their in vivo function in motor neurons and vasculature. Sci. Rep. 9, 1107 (2019).","journal-title":"Sci. Rep."},{"key":"10052_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.med.57.121304.131306","volume":"57","author":"J Folkman","year":"2006","unstructured":"Folkman, J. Angiogenesis. Annu. Rev. Med. 57, 1\u201318 (2006).","journal-title":"Annu. Rev. Med."},{"key":"10052_CR31","doi-asserted-by":"publisher","first-page":"a005090","DOI":"10.1101\/cshperspect.a005090","volume":"3","author":"DR Senger","year":"2011","unstructured":"Senger, D. R. & Davis, G. E. Angiogenesis. Cold Spring Harb. Perspect. Biol. 3, a005090 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10052_CR32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nri3737","volume":"14","author":"MS Macauley","year":"2014","unstructured":"Macauley, M. S., Crocker, P. R. & Paulson, J. C. Siglec-mediated regulation of immune cell function in disease. Nat. Rev. Immunol. 14, 653\u2013666 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"10052_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nmeth.1305","volume":"6","author":"Y Zeng","year":"2009","unstructured":"Zeng, Y., Ramya, T. N. C., Dirksen, A., Dawson, P. E. & Paulson, J. C. High-efficiency labeling of sialylated glycoproteins on living cells. Nat. Methods 6, 207\u2013209 (2009).","journal-title":"Nat. Methods"},{"key":"10052_CR34","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","volume":"17","author":"K Tzelepis","year":"2016","unstructured":"Tzelepis, K. et al. A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia. Cell Rep. 17, 1193\u20131205 (2016).","journal-title":"Cell Rep."},{"key":"10052_CR35","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1021\/acschembio.1c00689","volume":"17","author":"D Bojar","year":"2022","unstructured":"Bojar, D. et al. A useful guide to lectin binding: machine-learning directed annotation of 57 unique lectin specificities. ACS Chem. Biol. 17, 2993\u20133012 (2022).","journal-title":"ACS Chem. Biol."},{"key":"10052_CR36","unstructured":"Lewis, A. L., Chen, X., Schnaar, R. L. & Varki, A. in Essentials of Glycobiology (eds Varki, A. et al.) Ch. 15 (Cold Spring Harbor Laboratory Press, 2015)."},{"key":"10052_CR37","unstructured":"Merry, C. L. R., Lindahl, U., Couchman, J. & Esko, J. D. in Essentials of Glycobiology (eds Varki, A. et al.) Ch. 17 (Cold Spring Harbor Laboratory Press, 2022)."},{"key":"10052_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/514","volume":"19","author":"C McCormick","year":"1998","unstructured":"McCormick, C. et al. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat. Genet. 19, 158\u2013161 (1998).","journal-title":"Nat. Genet."},{"key":"10052_CR39","doi-asserted-by":"publisher","first-page":"26265","DOI":"10.1074\/jbc.273.41.26265","volume":"273","author":"T Lind","year":"1998","unstructured":"Lind, T., Tufaro, F., McCormick, C., Lindahl, U. & Lidholt, K. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J. Biol. Chem. 273, 26265\u201326268 (1998).","journal-title":"J. Biol. Chem."},{"key":"10052_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34882-6","volume":"13","author":"F Leisico","year":"2022","unstructured":"Leisico, F. et al. Structure of the human heparan sulfate polymerase complex EXT1-EXT2. Nat. Commun. 13, 7110 (2022).","journal-title":"Nat. Commun."},{"key":"10052_CR41","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1083\/jcb.119.4.961","volume":"119","author":"G David","year":"1992","unstructured":"David, G., Bai, X. M., Van der Schueren, B., Cassiman, J. J. & Van den Berghe, H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J. Cell Biol. 119, 961\u2013975 (1992).","journal-title":"J. Cell Biol."},{"key":"10052_CR42","doi-asserted-by":"publisher","first-page":"20516","DOI":"10.1074\/jbc.M502065200","volume":"280","author":"J van den Born","year":"2005","unstructured":"van den Born, J. et al. Novel heparan sulfate structures revealed by monoclonal antibodies. J. Biol. Chem. 280, 20516\u201320523 (2005).","journal-title":"J. Biol. Chem."},{"key":"10052_CR43","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0003-9861(78)90180-7","volume":"185","author":"JR Farley","year":"1978","unstructured":"Farley, J. R., Nakayama, G., Cryns, D. & Segel, I. H. Adenosine triphosphate sulfurylase from Penicillium chrysogenum equilibrium binding, substrate hydrolysis, and isotope exchange studies. Arch. Biochem. Biophys. 185, 376\u2013390 (1978).","journal-title":"Arch. Biochem. Biophys."},{"key":"10052_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/JCI200113530","volume":"108","author":"JD Esko","year":"2001","unstructured":"Esko, J. D. & Lindahl, U. Molecular diversity of heparan sulfate. J. Clin. Invest. 108, 169\u2013173 (2001).","journal-title":"J. Clin. Invest."},{"key":"10052_CR45","doi-asserted-by":"publisher","first-page":"23107","DOI":"10.1074\/jbc.M302203200","volume":"278","author":"J Lai","year":"2003","unstructured":"Lai, J. et al. Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. J. Biol. Chem. 278, 23107\u201323117 (2003).","journal-title":"J. Biol. Chem."},{"key":"10052_CR46","doi-asserted-by":"publisher","first-page":"49175","DOI":"10.1074\/jbc.M205131200","volume":"277","author":"M Morimoto-Tomita","year":"2002","unstructured":"Morimoto-Tomita, M., Uchimura, K., Werb, Z., Hemmerich, S. & Rosen, S. D. Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J. Biol. Chem. 277, 49175\u201349185 (2002).","journal-title":"J. Biol. Chem."},{"key":"10052_CR47","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/glycob\/9.7.705","volume":"9","author":"K Ono","year":"1999","unstructured":"Ono, K., Hattori, H., Takeshita, S., Kurita, A. & Ishihara, M. Structural features in heparin that interact with VEGF165 and modulate its biological activity. Glycobiology 9, 705\u2013711 (1999).","journal-title":"Glycobiology"},{"key":"10052_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4204\/EPTCS.125.3","volume":"2013","author":"Y Chen","year":"2013","unstructured":"Chen, Y., Short, C., Hal\u00e1sz, A. M. & Edwards, J. S. The impact of high density receptor clusters on VEGF signaling. Electron. Proc. Theor. Comput. Sci. 2013, 37\u201352 (2013).","journal-title":"Electron. Proc. Theor. Comput. Sci."},{"key":"10052_CR49","doi-asserted-by":"publisher","first-page":"117793222210850","DOI":"10.1177\/11779322221085078","volume":"16","author":"E G\u00fcven","year":"2022","unstructured":"G\u00fcven, E., Wester, M. J., Edwards, J. S. & Hal\u00e1sz, \u00c1M. Modeling the cluster size distribution of vascular endothelial growth factor (VEGF) receptors. Bioinform. Biol. Insights 16, 11779322221085078 (2022).","journal-title":"Bioinform. Biol. Insights"},{"key":"10052_CR50","doi-asserted-by":"publisher","first-page":"22272","DOI":"10.1074\/jbc.273.35.22272","volume":"273","author":"M Migdal","year":"1998","unstructured":"Migdal, M. et al. Neuropilin-1 is a placenta growth factor-2 receptor. J. Biol. Chem. 273, 22272\u201322278 (1998).","journal-title":"J. Biol. Chem."},{"key":"10052_CR51","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0092-8674(00)81402-6","volume":"92","author":"S Soker","year":"1998","unstructured":"Soker, S., Takashima, S., Miao, H. Q., Neufeld, G. & Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735\u2013745 (1998).","journal-title":"Cell"},{"key":"10052_CR52","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1083\/jcb.122.4.933","volume":"122","author":"S Higashiyama","year":"1993","unstructured":"Higashiyama, S., Abraham, J. A. & Klagsbrun, M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J. Cell Biol. 122, 933\u2013940 (1993).","journal-title":"J. Cell Biol."},{"key":"10052_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2020.03.011","volume":"78","author":"M Corley","year":"2020","unstructured":"Corley, M., Burns, M. C. & Yeo, G. W. How RNA-binding proteins interact with RNA: molecules and mechanisms. Mol. Cell 78, 9\u201329 (2020).","journal-title":"Mol. Cell"},{"key":"10052_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201800315","volume":"19","author":"AK Madugundu","year":"2019","unstructured":"Madugundu, A. K. et al. Integrated transcriptomic and proteomic analysis of primary human umbilical vein endothelial cells. Proteomics 19, e1800315 (2019).","journal-title":"Proteomics"},{"key":"10052_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01738-3","volume":"8","author":"HM Eilken","year":"2017","unstructured":"Eilken, H. M. et al. Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1. Nat. Commun. 8, 1574 (2017).","journal-title":"Nat. Commun."},{"key":"10052_CR56","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4161\/cam.28229","volume":"8","author":"AK Lagendijk","year":"2014","unstructured":"Lagendijk, A. K., Yap, A. S. & Hogan, B. M. Endothelial cell\u2013cell adhesion during zebrafish vascular development. Cell Adh. Migr. 8, 136\u2013145 (2014).","journal-title":"Cell Adh. Migr."},{"key":"10052_CR57","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0167-4781(97)00233-9","volume":"1397","author":"D Liang","year":"1998","unstructured":"Liang, D. et al. Cloning and characterization of vascular endothelial growth factor (VEGF) from zebrafish, Danio rerio. Biochim. Biophys. Acta 1397, 14\u201320 (1998).","journal-title":"Biochim. Biophys. Acta"},{"key":"10052_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0925-4773(01)00468-3","volume":"108","author":"D Liang","year":"2001","unstructured":"Liang, D. et al. The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech. Dev. 108, 29\u201343 (2001).","journal-title":"Mech. Dev."},{"key":"10052_CR59","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1242\/dev.137901","volume":"143","author":"M Shin","year":"2016","unstructured":"Shin, M. et al. Vegfc acts through ERK to induce sprouting and differentiation of trunk lymphatic progenitors. Development 143, 3785\u20133795 (2016).","journal-title":"Development"},{"key":"10052_CR60","first-page":"2301","volume":"23","author":"BS Zeidan","year":"1991","unstructured":"Zeidan, B. S., Waltzer, W. C., Monheit, A. G. & Rapaport, F. T. Anemia associated with pregnancy in a cyclosporine-treated renal allograft recipient. Transplant. Proc. 23, 2301\u20132303 (1991).","journal-title":"Transplant. Proc."},{"key":"10052_CR61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/dbio.2002.0711","volume":"248","author":"ND Lawson","year":"2002","unstructured":"Lawson, N. D. & Weinstein, B. M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248, 307\u2013318 (2002).","journal-title":"Dev. Biol."},{"key":"10052_CR62","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers, H. & Nusse, R. Wnt\/\u03b2-catenin signaling and disease. Cell 149, 1192\u20131205 (2012).","journal-title":"Cell"},{"key":"10052_CR63","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse, R. & Clevers, H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 169, 985\u2013999 (2017).","journal-title":"Cell"},{"key":"10052_CR64","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/1535370213514322","volume":"239","author":"JK Robertson","year":"2014","unstructured":"Robertson, J. K. et al. Targeting the Wnt pathway in zebrafish as a screening method to identify novel therapeutic compounds. Exp. Biol. Med. 239, 169\u2013176 (2014).","journal-title":"Exp. Biol. Med."},{"key":"10052_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-12-44","volume":"12","author":"S Kumar","year":"2014","unstructured":"Kumar, S. et al. Molecular dissection of Wnt3a-Frizzled8 interaction reveals essential and modulatory determinants of Wnt signaling activity. BMC Biol. 12, 44 (2014).","journal-title":"BMC Biol."},{"key":"10052_CR66","doi-asserted-by":"publisher","unstructured":"Ramakrishnan, A.-B. & Cadigan, K. M. Wnt target genes and where to find them. F1000Research https:\/\/doi.org\/10.12688\/f1000research.11034.1 (2017).","DOI":"10.12688\/f1000research.11034.1"},{"key":"10052_CR67","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbrc.2013.09.144","volume":"441","author":"F Gu","year":"2013","unstructured":"Gu, F. et al. VEGF111b, a new member of VEGFxxxb isoforms and induced by mitomycin C, inhibits angiogenesis. Biochem. Biophys. Res. Commun. 441, 18\u201324 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10052_CR68","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.cell.2014.04.033","volume":"157","author":"SM Eswarappa","year":"2014","unstructured":"Eswarappa, S. M. et al. Programmed translational readthrough generates antiangiogenic VEGF-Ax. Cell 157, 1605\u20131618 (2014).","journal-title":"Cell"},{"key":"10052_CR69","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/10739680902997333","volume":"16","author":"J Woolard","year":"2009","unstructured":"Woolard, J., Bevan, H. S., Harper, S. J. & Bates, D. O. Molecular diversity of VEGF-A as a regulator of its biological activity. Microcirculation 16, 572\u2013592 (2009).","journal-title":"Microcirculation"},{"key":"10052_CR70","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrm1911","volume":"7","author":"A-K Olsson","year":"2006","unstructured":"Olsson, A.-K., Dimberg, A., Kreuger, J. & Claesson-Welsh, L. VEGF receptor signalling \u2014 in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359\u2013371 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10052_CR71","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0969-2126(98)00065-3","volume":"6","author":"WJ Fairbrother","year":"1998","unstructured":"Fairbrother, W. J., Champe, M. A., Christinger, H. W., Keyt, B. A. & Starovasnik, M. A. Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure 6, 637\u2013648 (1998).","journal-title":"Structure"},{"key":"10052_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009945","volume":"5","author":"T-Y Lee","year":"2010","unstructured":"Lee, T.-Y., Folkman, J. & Javaherian, K. HSPG-binding peptide corresponding to the exon 6a-encoded domain of VEGF inhibits tumor growth by blocking angiogenesis in murine model. PLoS ONE 5, e9945 (2010).","journal-title":"PLoS ONE"},{"key":"10052_CR73","doi-asserted-by":"publisher","first-page":"28045","DOI":"10.1074\/jbc.M700319200","volume":"282","author":"D Krilleke","year":"2007","unstructured":"Krilleke, D. et al. Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J. Biol. Chem. 282, 28045\u201328056 (2007).","journal-title":"J. Biol. Chem."},{"key":"10052_CR74","doi-asserted-by":"publisher","first-page":"26031","DOI":"10.1016\/S0021-9258(18)35712-0","volume":"267","author":"KA Houck","year":"1992","unstructured":"Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J. & Ferrara, N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267, 26031\u201326037 (1992).","journal-title":"J. Biol. Chem."},{"key":"10052_CR75","doi-asserted-by":"crossref","unstructured":"Li, Z. et al. Cell-surface RNA forms ternary complex with RNA-binding proteins and heparan sulfate to recruit immune receptors. Mol. Cell 85, 4633-4650.e11 (2025).","DOI":"10.1016\/j.molcel.2025.11.020"},{"key":"10052_CR76","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang, K. C. & Chang, H. Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 43, 904\u2013914 (2011).","journal-title":"Mol. Cell"},{"key":"10052_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2014.03.008","volume":"157","author":"TR Cech","year":"2014","unstructured":"Cech, T. R. & Steitz, J. A. The noncoding RNA revolution \u2014 trashing old rules to forge new ones. Cell 157, 77\u201394 (2014).","journal-title":"Cell"},{"key":"10052_CR78","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp, F. & Mendell, J. T. Functional classification and experimental dissection of long noncoding RNAs. Cell 172, 393\u2013407 (2018).","journal-title":"Cell"},{"key":"10052_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121032","volume":"276","author":"Z Wan","year":"2021","unstructured":"Wan, Z. et al. A robust vasculogenic microfluidic model using human immortalized endothelial cells and Thy1 positive fibroblasts. Biomaterials 276, 121032 (2021).","journal-title":"Biomaterials"},{"key":"10052_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"10052_CR81","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR\u2013Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"10052_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30261-3","volume":"13","author":"CP Watkins","year":"2022","unstructured":"Watkins, C. P., Zhang, W., Wylder, A. C., Katanski, C. D. & Pan, T. A multiplex platform for small RNA sequencing elucidates multifaceted tRNA stress response and translational regulation. Nat. Commun. 13, 2491 (2022).","journal-title":"Nat. Commun."},{"key":"10052_CR83","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1089\/cmb.2017.0096","volume":"24","author":"A Kechin","year":"2017","unstructured":"Kechin, A., Boyarskikh, U., Kel, A. & Filipenko, M. cutPrimers: a new tool for accurate cutting of primers from reads of targeted next generation sequencing. J. Comput. Biol. 24, 1138\u20131143 (2017).","journal-title":"J. Comput. Biol."},{"key":"10052_CR84","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41596-022-00765-9","volume":"18","author":"R Ge","year":"2023","unstructured":"Ge, R. et al. m6A-SAC-seq for quantitative whole transcriptome m6A profiling. Nat. Protoc. 18, 626\u2013657 (2023).","journal-title":"Nat. Protoc."},{"key":"10052_CR85","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"10052_CR86","doi-asserted-by":"crossref","unstructured":"Smith, T., Monti, M., Willis, A. E. & Kalm\u00e1r, L. Benchmarking tRNA-seq quantification approaches by realistic tRNA-seq data simulation identifies two novel approaches with higher accuracy. eLife 13, RP96955 (2024).","DOI":"10.7554\/eLife.96955"},{"key":"10052_CR87","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.78861","volume":"11","author":"A Kuo","year":"2022","unstructured":"Kuo, A. et al. Murine endothelial serine palmitoyltransferase 1 (SPTLC1) is required for vascular development and systemic sphingolipid homeostasis. eLife 11, e78861 (2022).","journal-title":"eLife"},{"key":"10052_CR88","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.devcel.2020.01.016","volume":"52","author":"K Yanagida","year":"2020","unstructured":"Yanagida, K. et al. Sphingosine 1-phosphate receptor signaling establishes AP-1 gradients to allow for retinal endothelial cell specialization. Dev. Cell 52, 779\u2013793.e7 (2020).","journal-title":"Dev. Cell"},{"key":"10052_CR89","doi-asserted-by":"publisher","unstructured":"Wang, J., Yang, Z. & Xiao, A. Double-check the zebrafish 18S rRNA qPCR primers: they may be wrong. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.10.23.464780 (2021).","DOI":"10.1101\/2021.10.23.464780"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-10052-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-10052-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-10052-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:06:32Z","timestamp":1773839192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-10052-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":89,"journal-issue":{"issue":"8106","published-print":{"date-parts":[[2026,3,19]]}},"alternative-id":["10052"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-10052-8","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"16 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.A.F. is a stockholder of ORNA Therapeutics; and a board of directors member and stockholder of Blue Planet Systems. K.T. is a shareholder of and has received research funding from Storm Therapeutics. R.A.F., E.C. and P.C. have filed a patent related to HS-targeting domains. J.D.E. is a co-founder of TEGA Therapeutics. J.D.E. and The Regents of the University of California have licensed a University invention to and have an equity interest in TEGA Therapeutics. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. R.A.F. and P.C. have filed a patent related to the use of RNase for the modulation of growth factor activity. R.A.F., P.C. and E.C. have filed a patent related to the development and use of RNA-binding mutant growth factors. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}